BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
21 results:

  • 1. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study.
    Feng J; Zhang Y; Huang C; Li L; Liu J; Wang J; Guo H; Yao S; Cui Z; Chen G; Gao Q; Sun C; Ma D; Wang B; Li Y; Chu R; Kong B
    Eur J Surg Oncol; 2024 Apr; 50(4):108261. PubMed ID: 38484494
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Factors affecting cervical cancer screening among Yemeni immigrant women in Klang Valley, Malaysia: A cross sectional study.
    Al-Oseely S; Abdul Manaf R; Ismail S
    PLoS One; 2023; 18(12):e0290152. PubMed ID: 38100481
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R).
    Kim SI; Nam SH; Hwangbo S; Kim Y; Cho HW; Suh DH; Song JY; Kim JW; Choi CH; Kim DY; Lee M
    Gynecol Oncol; 2023 Jun; 173():88-97. PubMed ID: 37105062
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Relationship between serum folate and CIN1 prognosis and its interaction with HR-HPV infection].
    Qi Z; Ding L; Meng D; Liu H; Wang J; Song L; Lyu YJ; Jia HX; Hao M; Tian ZQ; Wang JT
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):866-871. PubMed ID: 34407593
    [No Abstract]    [Full Text] [Related]  

  • 5. Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis.
    Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Mogi K; Kajiyama H
    J Gynecol Oncol; 2021 Sep; 32(5):e66. PubMed ID: 34378361
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.
    Zhang C; Liao Y; Liu P; Du Q; Liang Y; Ooi S; Qin S; He S; Yao S; Wang W
    Theranostics; 2020; 10(15):6561-6580. PubMed ID: 32550890
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological cancer Group Study.
    Ørtoft G; Høgdall C; Hansen ES; Dueholm M
    J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
    Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
    Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.
    Buda A; Restaino S; Di Martino G; De Ponti E; Monterossi G; Dinoi G; Magni S; Quagliozzi L; Dell'Orto F; Ciccarone F; Lamanna M; Scambia G; Landoni F; Fanfani F
    Eur J Surg Oncol; 2018 Oct; 44(10):1562-1567. PubMed ID: 30077521
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer.
    Li M; Feng YM; Fang SQ
    Braz J Med Biol Res; 2017 Mar; 50(4):e5356. PubMed ID: 28355349
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer.
    Mahdi H; Munkarah AR; Ali-Fehmi R; Woessner J; Shah SN; Moslemi-Kebria M
    Arch Gynecol Obstet; 2015 Jul; 292(1):183-90. PubMed ID: 25549769
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Altered expression of survivin, fas and fasL contributed to cervical cancer development and metastasis.
    Wu SF; Zhang JW; Qian WY; Yang YB; Liu Y; Dong Y; Zhang ZB; Zhu YP; Feng YJ
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2044-50. PubMed ID: 23280017
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma.
    de Jong RA; Kema IP; Boerma A; Boezen HM; van der Want JJ; Gooden MJ; Hollema H; Nijman HW
    Gynecol Oncol; 2012 Sep; 126(3):474-80. PubMed ID: 22668882
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Resistance to chemotherapy and hormone therapy in endometrial cancer.
    Chaudhry P; Asselin E
    Endocr Relat Cancer; 2009 Jun; 16(2):363-80. PubMed ID: 19190080
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Apoptosis induction in Jurkat cells and scd95 levels in women's sera are related with the risk of developing cervical cancer.
    Aguilar-Lemarroy A; Romero-Ramos JE; Olimon-Andalon V; Hernandez-Flores G; Lerma-Diaz JM; Ortiz-Lazareno PC; Morgan-Villela G; Del Toro-Arreola S; Bravo-Cuellar A; Jave-Suarez LF
    BMC Cancer; 2008 Apr; 8():99. PubMed ID: 18405371
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression of fas ligand and bcl-2 in cervical carcinoma and their prognostic significance.
    Munakata S; Watanabe O; Ohashi K; Morino H
    Am J Clin Pathol; 2005 Jun; 123(6):879-85. PubMed ID: 15899779
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
    Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma.
    Sebastiani V; Visca P; Botti C; Santeusanio G; Galati GM; Piccini V; Capezzone de Joannon B; Di Tondo U; Alo PL
    Gynecol Oncol; 2004 Jan; 92(1):101-5. PubMed ID: 14751145
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. fas ligand expression in cervical adenocarcinoma: relevance to lymph node metastasis and tumor progression.
    Kase H; Aoki Y; Tanaka K
    Gynecol Oncol; 2003 Jul; 90(1):70-4. PubMed ID: 12821344
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. uterine papillary serous carcinoma--the KK Hospital experience.
    Ho TH; Lim TL; Tan HS
    Ann Acad Med Singap; 1998 Sep; 27(5):640-4. PubMed ID: 9919332
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.